Department of Health and Human Services· Notice
Outsourcing Facility Fee Rates for Fiscal Year 2024
effective in 65d
SUMMARY: The Food and Drug Administration (FDA) is announcing the fiscal year (FY) 2024 rates for the establishment and reinspection fees related to entities that compound human drugs and elect to register as outsourcing facilities under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FD&C Act authorizes FDA…
Owner check — Effective-date item: save the source and decide whether counsel, bookkeeping, or operations should review.